Magazines for Caregivers and Cancer Patients
Coping with Cancer
www.copingmag.com/cancer/ Coping® With Cancer is America's consumer magazine for people whose lives have been touched by cancer.. Now in its 22nd year of providing knowledge, hope and inspiration, its readers include cancer patients (survivors) and their families, caregivers, healthcare teams and support group leaders.
Women & Cancer
www.womenandcancermag.com Women & Cancer is the premier women's health and wellness magazine, delivering breaking news about topics critical to women making informed decisions about their own and their family's health and emphasizing cancer prevention, early detection, management, and survivorship.
As our readers face the challenges that a cancer diagnosis brings, we hope that the goodness that life has to offer, the lasting affection of friends and family and the remembrance of all of the women who have come through their experience with cancer as survivors, creating a legacy of hope for those who follow, will offer strength and inspiration.
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
